Which AI healthcare stocks have recently announced innovative technologies or partnerships?

Several AI healthcare stocks have recently announced innovative technologies or partnerships. Here are some notable examples: 1. **iRhythm Technologies (IRTC)**: iRhythm announced a partnership with Lucem Health to launch an AI-powered solution for earlier arrhythmia detection in high-risk patient groups. This partnership reflects a shift toward preventative healthcare and innovation in digital health solutions. 2. **Tempus AI (TEM)**: Tempus AI has been advancing precision oncology through AI-driven diagnostics and has recently secured a $200 million foundation model deal with AstraZeneca and Pathos. This partnership is a significant milestone in the company's aim to build a leading AI platform in oncology. 3. **Nephrolytics**: Nephrolytics has pioneered the first full-stack agentic AI solution specifically designed for nephrology, addressing workforce shortages and physician burnout. Their technology is moving the industry from legacy EMR systems to next-generation clinical intelligence platforms. 4. **GE HealthCare Technologies (GEHC)**: GE HealthCare has launched an AI-enabled digital X-ray system called Definium Pace Select ET1, which could revolutionize advanced imaging innovation. This launch is part of GE HealthCare's strategic focus on leveraging AI to enhance its healthcare offerings. 5. **Heartflow**: Heartflow has successfully raised $316.7 million in its initial public offering (IPO) on the US stock market. The company leverages AI technology to create detailed 3D models of the heart from a single specialized scan, improving the detection and treatment of coronary artery disease (CAD). These announcements demonstrate the ongoing innovation and advancement of AI technologies in healthcare, with a focus on improving patient outcomes, enhancing clinical workflows, and supporting the delivery of value-based care.